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Basement membrane proteoglycans and development. Basement mem-
branes contain distinct collagen, glycoprotein and proteoglycan spe-
cies, and these exhibit considerable heterogeneity in isoform or type
when different tissue types are compared. Additionally, many compo-
nents are differentially expressed in organogenesis. We have considered
the distributions in glomerulogenesis of two distinct basement mem-
brane proteoglycans, a small heparan sulfate proteoglycan and a
chondroitin sulfate proteoglycan (BM-CSPG). While the former was
present in all kidney basement membranes through development, the
latter was apparently regulated in distribution. BM-CSPG was only
strongly expressed in the vasculature invading late comma stage
glomeruli, and later in presumptive and mature Bowman's capsule.
Over the first six to eight weeks, the capillary basement membranes
contained BM-CSPG, but in gradually decreasing amounts until it
became completely undetectable. The basement membrane of the adult
rat glomerulus is unique in its lack of BM-CSPG. However, in diabetic
rats, BM-CSPG is apparently re-expressed in the glomerular basement
membrane, a potential marker for pathological changes in glomerular
structure. While its function awaits elucidation, BM-CSPG may be
essential for basement membrane integrity or stability and have impor-
tant roles in kidney development.
With the advent of detailed molecular descriptions of many of
the major basement membrane components and their receptors
[1—3] several features of these complex but specialized matrices
are becoming more apparent. First, many of the components
have potent biological activity and may influence tissue growth,
maturation and repair [4—6]. Second, these effects are likely
manifested through transmembrane events which in many cases
affect gene regulation [7, 8]. Third, the fine structure and
composition of basement membranes vary spatially and tempo-
rally, consistent with the notion that they impart modulatory
information to the cells with which they interact [9—111.
Much enlightening information regarding the role of base-
ment membranes as described above has come from studies of
both adult and embryonic kidney. In the case of the laminin
glycoproteins, it is clear that the organization of its constituent
chains varies from one site to another [12], and the A chain may
play important roles in the differentiation and polarity of
overlying epithelia [11]. Heterogeneity of structure of kidney
basement membrane matrices is also clearly seen when glomer-
ular capillary, mesangial, Bowman's capsule and tubular base-
ment membranes are compared [12—15]. The distribution of
laminin and type IV collagen variant chains and integrin recep-
tors is consistent with this heterogeneity [12, 16, 17]. The
importance of basement membranes in kidney function is
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underscored by changes in their organization resulting from
various nephropathies such as diabetes mellitus [18, 19], Al-
port's [20, 21] and Goodpasture's syndromes [22].
The selective permeability function of the glomerular capil-
lary loops has been suggested to lie in the structure and
organization of its basement membrane proteoglycan compo-
nent, particularly the heparan sulfate proteoglycans [23]. In-
deed, immunohistochemical and biochemical analyses of the
glomerular basement membrane show it to be enriched in these
macromolecules [13, 23—28]. Until recently, however, the het-
erogeneity in subunit composition and molecular organization
described for other basement membrane components did not
extend to the proteoglycan category. However, we have re-
cently described a chondroitin sulfate proteoglycan with unique
core protein as a component of many adult rat basement
membranes [15, 29]. The proteoglycan isolated from kidney has
a core protein of Mr approximately 150 k and may bear
numerous short chondroitin sulfate chains of Mr 16 to 18 k.
Furthermore, its distribution in the kidney highlights a remark-
able feature of this extracellular component. Of all basement
membranes examined with a panel of core protein-specific
antibodies, only the glomerular basement membrane was un-
stained [15, 29]. To date, all other basement membranes exam-
ined in the adult rat contain this component (denoted BM-
CSPG). This has prompted a detailed examination of
glomerulogenesis in the rat, to establish the developmental
changes which culminate in BM-CSPG heterogeneity in kidney
distribution. The results, though complex, show a clear pattern
of spatial and temporal regulation in BM-CSPG expression
which may be essential for normal kidney function when
diabetic kidneys are compared.
Methods
In these studies, the distributions of two basement membrane
proteoglycans were compared. Monospecific polyclonal anti-
bodies against a small heparan sulfate proteoglycan isolated
from culture supernatants of murine PYS-2 cells have been
previously described [24]. A panel of four core protein-specific
monoclonal antibodies raised against a chondroitin sulfate
proteoglycan isolated from rat Reichert's membranes have been
fully documented [15]. In the studies below, the 2D6 and 2B5
antibodies were used predominantly, these having the ability to
stain paraffin-embedded material [29].
Embryonic kidney, postnatal and adult kidney tissues were
fixed and embedded for light microscopy as previously de-
scribed [29], and sections were pretreated with bovine testicular
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Table 1. Distribution of basement membrane proteoglycans in
glomerulogenesis
Stage/structure BM-CSPG HSPG
Ureter and ureteric buds + + ÷+
Condensed mesenchyme + + + +
Comma stage figures + + + + +
Invading vasculature + + + + + +
"S" shaped figures
Presumptive Bowman's capsule + + + + +
Presumptive tubular bm's + + + + + +
Newly formed glomerulus
Capillary bm's +++ +++
Mesangium ++-i- +÷+
Bowman's capsule ++++ +++
8-Week-old glomerulus
Capillary bm's — ++++
Mesangium + + + + + + +
Bowman's capsule ++++ +++
Symbols are: (—) undetectable; (+) weak and/or patchy; (++)
present; (+ + +) strongly staining; (+ + + +) very strongly staining.
Abbreviation is: bm, basement membrane.
hyaluronidase before exposure to antibodies [30]. Where dou-
ble immunofluorescence microscopy was performed, primary
antibodies were followed by fluorescein isothiocyanate-conju-
gated goat anti-mouse IgG and tetramethylrhodamine isothio-
cyanate-conjugated goat anti-rabbit IgG. Controls were per-
formed to exclude possible inappropriate cross-reactivity of
secondary with primary antibodies as well as "breakthrough"
of the rhodamine image into the fluorescein wavelengths when
the sections were observed and photographed on a Nikon
Optiphot microscope [15]. Preimmune rabbit sera and normal
mouse IgG also gave negative results.
For immunoelectron microscopy, anesthetized adult and
postnatal rats of various ages were injected via the femoral vein
with horseradish peroxidase-conjugated anti-BM-CSPG anti-
bodies four hours before sacrifice. Kidneys were infiltrated in
situ with Karnovsky's fixative [31], and processed for peroxi-
dase visualization [32]. Tissues were then dehydrated, embed-
ded, sectioned and examined as previously described [33]. Full
details will be published elsewhere (McCarthy et al, submitted
for publication).
Results
In the late prenatal (18 to 21 days gestation) and early
postnatal (1 to 7 days) rat kidney, glomerulogenesis is a
continuous process, with a distinct gradient across the renal
cortex. The more mature figures are perimedullary, while those
that are less mature can be visualized towards the outer edge of
the cortex. Therefore, many stages of development can be
stained and analyzed in appropriate cross sections of the entire
cortical zone.
The results summarizing the distributions of basement mem-
brane HSPG and BM-CSPG are shown in Table 1. There was a
clear difference in the expression of the two proteoglycans, but
in general, we could only detect developmental regulation of the
BM-CSPG. In all basement membranes, we found HSPG to be
easily visualized, including those of ureteric buds, vesicles,
comma and S-shaped figures, invading vasculature as well as
the developing capillary ioop stage and mature glomerulus.
Quite distinct was the distribution of BM-CSPG. Initially
Fig. 1. Double immunofluorescence micrographs of BM-CSPG (A) and
HSPG (B) distribution in 18 day fetal rat kidney. While HSPG is
strongly expressed in all basement membranes, BM-CSPG is not
extensively expressed until vascularization of presumptive glomeruli is
completed (open arrow). Ureter and ureteric buds are virtually devoid
of staining, except at branch points (arrowhead). Vesicle stage figures
(curved arrow) are also weakly stained for BM-CSPG. A comma stage
glomerulus (arrow) is also present. Bar = 100 jim.
very sparse and weakly present, significant amounts were not
detected until after vascularization of the presumptive glomer-
uli (Fig. 1). It was interesting that small concentrations of
BM-CSPG were evident at branch points of the ureteric buds,
which may be important for their stabilization, The invading
vasculature was quite strongly BM-CSPG positive by indirect
immunofluorescence techniques, and perhaps consistent with
this, we noted bright staining associated with presumptive
mesangium and glomerular basement membrane of the devel-
oping capillary loop stage. Therefore, at this early stage of
development, but not in the adult [15, 29], the capillary loop
basement membrane contains BM-CSPG. This could be verified
by immunoelectron microscopy, where staining by direct im-
munoperoxidase techniques was evident both in the mesangial
matrix and capillary loops.
It was then apparent that at some postnatal stage, BM-CSPG
must be secondarily removed from the glomerular capillary
basement membranes, in order for the "adult" organization of
glomerular proteoglycans to be achieved. Immunofluorescence
staining of successively older rat kidneys (Fig. 2) revealed that
between six to eight weeks after birth, the glomerulus achieves
Couchman et alt Proteoglycans and development 81
Fig. 2. Distribution of BM-CSPG (A, C) and HSPG (B, D) in glomeruli of 7 day (A, B) and 56 day (C, D) postnatal rat kidneys. While BM-CSPG
is expressed in the glomerular capillary loops of early postnatal rats (arrows), this staining is lost by 42 to 56 days after birth. HSPG is strongly
stained in all glomerular capillary loop basement membranes. Bar = 50
its final mature state with regard to the absence of BM-CSPG.
Presumably the proteoglycan is slowly removed but not re-
placed. It is worth noting that immunoelectron microscopy of
glomerular capillary loops where BM-CSPG was present
showed it to be unevenly distributed across the basement
membrane. The lamina rara interna was much more heavily
stained than the lamina rara externa, perhaps indicative of
endothelial origin. Consistent with this are two other observa-
tions. First, the invading vasculature at the late comma stage
was strongly BM-CSPG positive. Second, where outpocketings
[34] of basement membrane adjacent to glomerular epithelial
cells of postnatal kidneys were observed, they were apparently
always lacking BM-CSPG. These outpocketings, which are
thought to be spliced into the maturing glomerular basement
membrane [34], are presumably of epithelial [35], rather than
vascular endothelial origin.
In the normal rat, the mature glomerular capillary basement
membrane does not contain detectable BM-CSPG, though the
basement membranes of the Bowman's capsule, proximal and
distal tubules and the mesangial matrix have readily discernable
BM-CSPG when both paraffin-embedded and frozen kidney
tissues were examined [15, 291. Moreover, even in adult rats
injected with anti-BM-CSPG, where potentially hidden epitopes
can be more readily displayed [331, no staining of the glomerular
basement membrane was elicited (Fig. 3). However, a striking
difference was noted in our preliminary studies of rats rendered
diabetic with intraperitoneal injections of streptozotocin [361.
Double immunofluorescence microscopy of kidneys from one,
two and three month time periods after induction of the diabetic
state, (verified by plasma glucose measurements, body weight
and polyuria) showed that BM-CSPG was now detectable in the
glomerular basement membranes. It was additionally present in
all other kidney basement membranes as before, but became
increasingly extensive in the expanding mesangium typical of
the diabetic state (Fig. 4).
It is well established that the glomerular capillary basement
membrane becomes thickened in the diabetic state [37, 38], and
this was noted by electron microscopy in our studies. However,
immunoelectron microscopy delineated deposits of BM-CSPG
in thickened regions of the glomerular capillary basement
membrane, once again strongly accentuated on internal por-
tions adjacent to the vascular endothelial cells.
Discussion
There have been several detailed and elegant studies of
kidney development [1, 11, 14, 34, 39—42], and successive
revisits to this remarkable process with new molecular and
immunological probes. Insight into the complex tissue interac-
tions which govern nephrogenesis is being slowly gained,
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Fig. 3. Immunoelectron micrograph of BM-CSPG distribution in an adult rat kidney glomerulus. The animal was intraveneously injected with
antibody/horseradish peroxidase conjugate 4 hours before sacrifice. The tissue was initially processed for HRP/cytochemistry (see text) with
subsequent processing and embedding for electron microscopy. The electron dense peroxidase reaction product, associated with BM-CSPG
immunolocalization, is present in the mesangial matrix (arrows) but not in the capillary loop basement membrane (arrowheads). Bar = 2 sm.
particularly with the ability to study processes in vitro. Base-
ment membranes are synthesized and assembled by the newly
formed epithelial structures during kidney development. This
may be an indicator of their importance, and other studies have
shown that disruption of proteoglycan synthesis may pro-
foundly affect branching morphogenesis at a very early stage of
kidney development [43, 44]. However, the identity of the
proteoglycan(s) that are required are unknown, though perhaps
galactosaminoglycan-bearing species are implicated from both
xyloside experiments, and other data supporting their role in
other systems characterized by branching morphogenesis [4,
45, 46].
It is possible, therefore, but by no means certain, that the
precise spatial and temporal expression of BM-CSPG is corre-
lated with important roles in nephrogenesis. The kidney is a
paradigm for developmental studies, and we have shown here
that full maturation of the glomerular capillary basement mem-
brane may not occur until six to eight weeks after birth in the
rat. Only at this point is BM-CSPG undetectable, and a marker
of the adult state, although morphologically, the capillary ioop
basement membrane is unchanged at these later stages. All the
data from our immunoelectron studies would support the con-
tention made previously [33, 35] that in the mature capillary
loop, the basement membrane is predominantly of epithelial
origin. It would seem that under normal circumstances, the
endothelial contribution to the basement membrane declines in
the first few weeks after birth. A recent result comparable with
the BM-CSPG data is that mRNA levels for the B1, B2 and A
chain of laminin change over several weeks after birth [11],
indicating that for another basement membrane component,
maturation takes place over an extended time period.
Quite unexpectedly, therefore, it appears that the develop-
mental program may be recapitulated in the streptozotocin
model of diabetes mellitus in the rat. BM-CSPG is once again
detectable in the capillary loop basement membrane, and may
be of endothelial origin, based on our preliminary immunoelec-
tron microscopy data. Testing of this hypothesis is currently
underway. Whether the renewed presence of BM-CSPG in the
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Fig. 4. Two months after streptozotocin treatment, immunostaining for BM-CSPG (A) is detectable in both the greatly expanded mesangium and
capillary loop basement membranes (arrows) of diabetic rats. The distribution of HSPG (B) is, however, essentially unaltered. Bar = 50 m.
diabetic capillary loop compromises filtration function is cur-
rently unknown, but of considerable interest. Previous data has
also drawn attention to the role of basement membrane proteo-
glycans in diabetes, but from the point of view of changes in
metabolism of the heparan sulfate component [47—51].
The function of BM-CSPG is currently unknown. Previous
studies on skin and hair follicle development in the rat [10],
have given essentially similar results to this study of kidney
development, that is, BM-CSPG is strongly regulated during
tissue morphogenesis. We must add the caveat that it remains
possible that epitopes recognized by the monoclonal antibodies
become sterically unavailable. However, even when antibodies
are injected into the living animal, BM-CSPG is not detectable
in the adult rat glomerular basement membrane. Why this
basement membrane alone in the adult should be unstained is
intriguing and potentially informative with regard to its possible
function. Previous studies by Beavan et a! have pointed out that
the half-life of basement membrane HSPG in the normal adult
rat is short, in the order of 5 to 20 hours [52]. It may be that
basement membranes are stabilized by BM-CSPG, which
would be consistent with its absence from mature glomerular
basement membrane, its late expression in developing base-
ment membranes, and the instability of the dermal-epidermal
junction of dystrophic epidermolysis bullosa patients where the
carbohydrate component of BM-CSPG is apparently altered
[53]. Future studies of the structure of BM-CSPG, its interac-
tions with other basement membrane components and experi-
mental manipulation of its synthesis may throw some light on
the biological role of heterogeneity in basement membrane
proteoglycans.
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